Operating Lease, Right-of-Use Asset of Fusion Pharmaceuticals Inc. from 31 Mar 2021 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fusion Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 31 Mar 2024.
  • Fusion Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $17,861,000, a 0.12% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Fusion Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $17,861,000 +$21,000 +0.12% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $18,592,000 +$12,908,000 +227% 31 Dec 2023 10-Q 07 May 2024 2024 Q1
Q3 2023 $19,518,000 +$13,546,000 +227% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $17,632,000 +$11,373,000 +182% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $17,840,000 +$11,296,000 +173% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,684,000 -$802,000 -12% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $5,972,000 -$974,000 -14% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $6,259,000 -$965,000 -13% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $6,544,000 +$5,644,000 +627% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $6,486,000 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $6,946,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $7,224,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $900,000 31 Mar 2021 10-Q 07 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.